Ulcerative colitis has several available treatments, including one from Pfizer. FDA approval of a new drug gives Pfizer an opportunity to expand its reach in this market with a molecule whose ...

Ulcerative Colitis Market grows at 5.4% CAGR (2025–2033), reaching US$ 12.79 Billion on rising biologic adoption, biosimilars, and personalized IBD therapies. North America leads the ulcerative ...

With ulcerative colitis (UC), it may feel like each day presents a new hurdle. You can get your symptoms under control and keep them in remission with treatment, yet because of the somewhat ...

Key Takeaways Oral small-molecule therapies are redefining first-line treatment in moderate to severe ulcerative colitis (UC) by offering noninfusion alternatives with rapid onset and high efficacy.

Credit: Getty Images Researchers developed a guide for clinicians to use ozanimod for the treatment of moderate to severe ulcerative colitis. Ulcerative colitis (UC) is a chronic and relapsing type of ...

In certain patients, JAK inhibitor rescue medications seem to be more effective, researche ...

Omvoh achieved primary and key secondary endpoints, including sustained clinical remission in pivotal trials Omvoh delivered significant improvement in bowel urgency, reported by people with UC as one ...

Maxim Group analyst Naz Rahman maintained a Buy rating on Palisade Bio (PALI – Research Report) yesterday and set a price target of $22.50. Naz Rahman has given his Buy rating due to a combination of ...

Ulcerative colitis (UC) can be described in many ways through a variety of symptoms, but only those who live with it every day know how detrimental it can truly be. At first, the pain was terrifying.

What Is Proctitis and How Does It Compare to UC? Proctitis is inflammation of the rectum, the last part of the large intestine that connects the colon to the anus. Ulcerative colitis (UC) is a type of ...

INDIANAPOLIS, Oct. 26, 2023 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that the U.S. Food and Drug Administration (FDA) has approved Omvoh™ (mirikizumab-mrkz) infusion (300 ...